Issue 5: Diabetes and Global Health

Chronic non-communicable diseases (NCDs), including diabetes, cardiovascular disease, cancer and chronic respiratory disease, pose a significant burden across the globe. Our first issue of 2011 examines diabetes globally and spotlights noteworthy advocacy and community initiatives in the US.


Expert Q&A with Lars Rebien Sørensen

On January 28, 2011, Lars Rebien Sørensen, President and CEO, Novo Nordisk participated in the "Raising Healthy Children" panel at the World Economic Forum 2011 Annual Meeting in Davos, Switzerland.

Read the full article

Global Health Takes Center Stage

What do Bono, Ban Ki-moon, and Lars Rebien Sørensen, the President and Chief Executive Officer of Novo Nordisk all have in common?

Read the full article

Community Solutions

A Look at the New DPCA

What will the future bring? According to the 2011 National Diabetes Fact Sheet from the Centers for Disease Control and Prevention (CDC), diabetes currently affects 25.8 million people in the U.S.

Read the full article

Diabetes in the US

New Data from the CDC

Diabetes affects 25.8 million people – 8.3% of the U.S. population.

Read the full article

Government Update

Advocacy in Action

An overview on Novo Nordisk's advocacy efforts in increasing diabetes prevention, detection, treatment and care funding and resources in the U.S.

Read the full article

BlueSheet Newsletter: Issue 5

(Downloadable Print-Ready Version)

BlueSheet Newsletter: Issue 5 (Downloadable Print-Ready Version)

Read the entire newsletter

Readership Survey

Please take a few minutes to complete our readership survey.

Readership Survey

© 2011 Novo Nordisk 143855 March 2011.

For more information please contact:
Ken Inchausti
Director, Media Relations, Communications and Public Affairs
kiau@novonordisk.com
Phone: 609-786-8316 (direct)